首页> 外文OA文献 >PMS29 CANADIAN COST-EFFECTIVENESS ANALYSIS OF ABATACEPT (ORENCIA™) FOR THE MANAGEMENT OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS IN PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE

【2h】

PMS29 CANADIAN COST-EFFECTIVENESS ANALYSIS OF ABATACEPT (ORENCIA™) FOR THE MANAGEMENT OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS IN PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE

机译：PMS29 ABATACEPT（ORENCIA™）用于治疗对甲氨蝶呤反应不佳的中度至重度活动性类风湿关节炎的成本效益分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zou D; Desjardins O; Tsao N; Goeree R;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate. [J] . Vera-Llonch M, Massarotti E, Wolfe F, Rheumatology . 2008,第4期

机译：阿巴西普在中度至重度活动性类风湿关节炎和对甲氨蝶呤反应不足的患者中的成本效益。
2. Cost–effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate [J] . M. Vera-Llonch1 E. Massarotti2 F. Wolfe3 N. Shadick4 R. Westhovens5 O. Sofrygin1 R. Maclean6 Y. Yuan6 and G. Oster1 Rheumatology . 2008,第4期

机译：阿巴西普在中度至重度活动性类风湿关节炎和对甲氨蝶呤反应不足的患者中的成本效益
3. Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists. [J] . Vera-Llonch M, Massarotti E, Wolfe F, The Journal of rheumatology . 2008,第9期

机译：阿巴西普在中度至重度活动性类风湿关节炎患者中的成本效益，且对肿瘤坏死因子-α拮抗剂的反应不足。
4. No adverse physiological responses to infrared whole body hyperthermia in patients with rheumatoid arthritis and ankylosing spondylitis compared to healthy subjects. [C] . F.G.J. OOSTERVELD, E. KOOPMAN, J. OLDE SCHOLTENHUIS, Advances in biomedical research . 2010

机译：与健康受试者相比，类风湿性关节炎和强直性脊柱炎患者对红外全身热疗没有不利的生理反应。
5. Affective Responses to Laboratory Stressors in Rheumatoid Arthritis Patients A Comparison of Mindfulness-based Emotion Regulation and Cognitive Behavioral Interventions. [D] . Arewasikporn, Anne. 2012

机译：类风湿关节炎患者对实验室应激源的情感反应基于正念的情绪调节和认知行为干预的比较。
6. Efficacy and safety of abatacept for patients with Sjögrens syndrome associated with rheumatoid arthritis: Rheumatoid Arthritis with Orencia Trial toward Sjögrens syndrome Endocrinopathy (ROSE) trial—an open-label one-year prospective study—Interim analysis of 32 patients for 24 weeks [O] . Hiroto Tsuboi, Isao Matsumoto, Shinya Hagiwara, -1

机译：阿巴西普对类风湿性关节炎干燥综合征患者的疗效和安全性：类风湿性关节炎Orencia试验用于干燥综合征的内分泌病（ROSE）试验（一项开放性前瞻性前瞻性研究）对32例患者进行了为期24周的中期分析
7. Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate [O] . M. Vera-Llonch, E. Massarotti, F. Wolfe, 2007

机译：患者中度患者的成本效果，以严重有活性的类风湿性关节炎和对甲氨蝶呤的反应不足

PMS29 CANADIAN COST-EFFECTIVENESS ANALYSIS OF ABATACEPT (ORENCIA™) FOR THE MANAGEMENT OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS IN PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE

著录项

引文网络

相似文献

相关主题

期刊订阅